Our ABML Play seems to be working out so far. Here is another Gem that could work our similar. I love cheap stocks.
NOVN is a clinical development-stage biotechnology company, which focuses on the development and commercialization of nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases.
Checking Wallstreetzen, it appears to be backed by all the big boys like Vanguard, Blackrock, Renaissance etc...
The company is developing a treatment for Molluscum Contagiosum, soon to be the only one FDA approved for Molluscum treatment if everything goes well.
The readout for their B206 trial in June is expected to arrive with positive results from the data.
Entry : $1.45
TP : $3
SL : $1
Let's see how this plays out.
(Disclaimer, not financial advice)
NASDAQ:NOVN
NOVN is a clinical development-stage biotechnology company, which focuses on the development and commercialization of nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases.
Checking Wallstreetzen, it appears to be backed by all the big boys like Vanguard, Blackrock, Renaissance etc...
The company is developing a treatment for Molluscum Contagiosum, soon to be the only one FDA approved for Molluscum treatment if everything goes well.
The readout for their B206 trial in June is expected to arrive with positive results from the data.
Entry : $1.45
TP : $3
SL : $1
Let's see how this plays out.
(Disclaimer, not financial advice)
NASDAQ:NOVN
